244 related articles for article (PubMed ID: 38790190)
1. Sarcopenia as a Risk Factor for Alzheimer's Disease: Genetic and Epigenetic Perspectives.
Raleigh SM; Orchard KJA
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790190
[TBL] [Abstract][Full Text] [Related]
2. Genetic factors associated with the predisposition to late onset Alzheimer's disease.
Durmaz A; Kumral E; Durmaz B; Onay H; Aslan GI; Ozkinay F; Pehlivan S; Orman M; Cogulu O
Gene; 2019 Jul; 707():212-215. PubMed ID: 31102717
[TBL] [Abstract][Full Text] [Related]
3. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.
Gomar JJ; Conejero-Goldberg C; Huey ED; Davies P; Goldberg TE;
Neurobiol Aging; 2016 Mar; 39():165-73. PubMed ID: 26923413
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of Alzheimer's disease and aging.
Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
[TBL] [Abstract][Full Text] [Related]
5. Regulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction.
Butler AA; Webb WM; Lubin FD
Epigenomics; 2016 Jan; 8(1):135-51. PubMed ID: 26366811
[TBL] [Abstract][Full Text] [Related]
6. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T
Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic study of an Alzheimer's disease family with monozygotic triplets.
Zhang M; Dilliott AA; Khallaf R; Robinson JF; Hegele RA; Comishen M; Sato C; Tosto G; Reitz C; Mayeux R; George-Hyslop PS; Freedman M; Rogaeva E
Brain; 2019 Nov; 142(11):3375-3381. PubMed ID: 31580390
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease.
Nacmias B; Piccini C; Bagnoli S; Tedde A; Cellini E; Bracco L; Sorbi S
Neurosci Lett; 2004 Sep; 367(3):379-83. PubMed ID: 15337270
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's Disorder: Epigenetic Connection and Associated Risk Factors.
Sharma VK; Mehta V; Singh TG
Curr Neuropharmacol; 2020; 18(8):740-753. PubMed ID: 31989902
[TBL] [Abstract][Full Text] [Related]
10. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele.
Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A
Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623
[TBL] [Abstract][Full Text] [Related]
11. Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms.
Matuskova V; Veverova K; Jester DJ; Matoska V; Ismail Z; Sheardova K; Horakova H; Cerman J; Laczó J; Andel R; Hort J; Vyhnalek M
Alzheimers Res Ther; 2024 Jan; 16(1):21. PubMed ID: 38279143
[TBL] [Abstract][Full Text] [Related]
12. Moderate treadmill exercise ameliorates amyloid-β-induced learning and memory impairment, possibly via increasing AMPK activity and up-regulation of the PGC-1α/FNDC5/BDNF pathway.
Azimi M; Gharakhanlou R; Naghdi N; Khodadadi D; Heysieattalab S
Peptides; 2018 Apr; 102():78-88. PubMed ID: 29309801
[TBL] [Abstract][Full Text] [Related]
13. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Laws SM; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Rembach A; Martins RN; Rowe CC; Masters CL; Maruff P
Mol Psychiatry; 2015 Nov; 20(11):1322-8. PubMed ID: 25288138
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNAs and Alzheimer's disease.
Luo Q; Chen Y
Clin Interv Aging; 2016; 11():867-72. PubMed ID: 27418812
[TBL] [Abstract][Full Text] [Related]
15. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease.
Lim YY; Hassenstab J; Cruchaga C; Goate A; Fagan AM; Benzinger TL; Maruff P; Snyder PJ; Masters CL; Allegri R; Chhatwal J; Farlow MR; Graff-Radford NR; Laske C; Levin J; McDade E; Ringman JM; Rossor M; Salloway S; Schofield PR; Holtzman DM; Morris JC; Bateman RJ;
Brain; 2016 Oct; 139(Pt 10):2766-2777. PubMed ID: 27521573
[TBL] [Abstract][Full Text] [Related]
16. The association between sarcopenia susceptibility and polymorphisms of FTO, ACVR2B, and IRS1 in Tibetans.
Zhang X; Ye L; Li X; Chen Y; Jiang Y; Li W; Wen Y
Mol Genet Genomic Med; 2021 Aug; 9(8):e1747. PubMed ID: 34302448
[TBL] [Abstract][Full Text] [Related]
17. Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration.
Honea RA; Cruchaga C; Perea RD; Saykin AJ; Burns JM; Weinberger DR; Goate AM;
PLoS One; 2013; 8(9):e76001. PubMed ID: 24086677
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic drugs in Alzheimer's disease.
Cuadrado-Tejedor M; Oyarzabal J; Lucas MP; Franco R; García-Osta A
Biomol Concepts; 2013 Oct; 4(5):433-45. PubMed ID: 25436752
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease.
He C; Huang ZS; Yu CC; Wang HH; Zhou H; Kong LH
Curr Med Sci; 2020 Dec; 40(6):1022-1030. PubMed ID: 33428129
[TBL] [Abstract][Full Text] [Related]
20. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
Bian JT; Zhang JW; Zhang ZX; Zhao HL
Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
